Ortho Clinical Diagnostics Holdings PLC Closes $1.49 Billion Initial Public Offering of Ordinary Shares Trading on the NASDAQ Global Select Market

CFGI’s Capital Markets team assisted Ortho Clinical Diagnostics Holdings PLC (NASDAQ: OCDX) with their initial public offering.

More

Clene Nanomedicine Inc. Closes Business Combination with SPAC Tottenham Acquisition I Limited

CFGI’s Capital Markets team assisted Clene Nanomedicine (“Clene”) (NYSE: CLNN) with its SPAC merger with Tottenham Acquisition I Limited (“Tottenham”).

More

Meet Robert Keep: CFGI’s Boston Office Leader and Accounting Advisory Expert

CFGI’s Robert Keep may be English by birth, but he’s a Bostonian through and through.

More

Olema Pharmaceuticals Closes $209 Million Initial Public Offering with Support from CFGI

CFGI’s Capital Markets team supported Olema Pharmaceuticals (Nasdaq: OLMA) with an initial public offering of 11,000,000 shares of common stock priced at $19.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Matt Estadt Jumpstarts CFGI’s Transaction Advisory Services

If you want to succeed in the transaction services field, you need to stand out.

More

FASB simplifies issuer’s accounting for certain debt and equity instruments through the elimination of the ‘beneficial conversion feature’ and ‘cash conversion feature’ separation models and changes to equity classification criteria

Summary The FASB has simplified the accounting for convertible debt and equity instruments and contracts issued in an entity’s own equity with the issuance of ASU 2020-06.

More

Vital Farms Closes $111 Million Initial Public Offering with Support from CFGI

CFGI’s Capital Markets team supported Vital Farms (Nasdaq: VITL) with an initial public offering of 5,040,323 shares of common stock priced at $22.

More

Fusion Pharma Closes $212.5 million initial public offering with support from CFGI

CFGI’s Capital Markets team announced that it assisted Fusion Pharmaceuticals (NASDAQ: FUSN) with an initial public offering of 12,500,000 common shares at $17 per share for gross proceeds of $212.

More